Celularity (CELU)
Celularity Inc., a cellular and regenerative medicine company, focuses on addressing aging-related disease using novel therapies. The company operates through t...
- Open
- 1.420
- High
- 1.964
- Low
- 1.380
- Prev. Close
- 1.580
- Volume
- 3.17M
- Turnover
- 5.30M
- Avg Price
- 1.671
- Bid/Ask Ratio
- -99.71%
- Amplitude
- 36.96%
- 52wk High
- 4.000
- Volume Ratio
- 82.30
- Turnover Ratio
- 16.80%
Celularity Analyst Rating
View moreForecast & Rating
Jun 22, 2023Price forecast
$25.001238.33%
Forecast & RatingBuy
1analysts
- Strong buy0.00%
- Buy100.00%
- Hold0.00%
- Sell0.00%
- Strong sell0.00%
News
- Weekly Review · 2 days ago, 12:28 AM
Weekly Recap | Celularity +97.48%, Nasdaq compliance overhang persists
- benzinga_article · Aug 27 at 12:06 PM
12 Health Care Stocks Moving In Thursday's Intraday Session
- benzinga_article · Aug 27 at 09:18 AM
Celularity shares are trading higher after the company announced an additional U.S.-based manufacturing collaboration under which Celularity will undertake activities to establish U.S. production of Dezawa MuseCells at Celularity’s Florham Park, New Jersey facility.
- Price Alert · Aug 27 at 08:18 AM
Pre-market hot trades in US stocks: Celularity up 22.65% in pre-market; Quanta Services up 3.44% in pre-market
- PUBT · Aug 27 at 08:00 AM
Celularity partners with MuseCell Innovations on U.S. manufacturing for Dezawa MuseCell platform
- PUBT · Aug 26 at 05:10 AM
Celularity risks Nasdaq noncompliance over late SEC quarterly filings
